Egyptian medical education platform 30Med secures pre-seed funding

Egypt-based medical education platform 30Med has secured an unspecified amount in pre-seed funding from anonymous angel investors — propelling it into a new phase of growth and innovation.

Founded by Doctor Ayman Ragab, 30Med aims to revolutionize how physicians engage with medical education by bridging the gap between pharmaceutical companies and physicians. To that end, the company leverages interactive videos and conference events to showcase new medicines and facilitate ongoing learning.

This pre-seed funding provides the company with the necessary resources to further develop its platform and expand its reach within the medical community.

30Med has already achieved traction within the medical community, with its current user base comprising doctors who are eager to stay informed and engaged with the latest advancements in medicine and pharmaceuticals.

On the other hand, the company has struck strategic partnerships with leading pharmaceutical companies in Egypt — providing them with a seamless avenue to showcase new medicines to interested audiences.